PubMed, Kulanuwat, Sirikul, et al
GLP-1 Market Trends The shift from injectables to oral GLP-1 formulations, like recent FDA approvals and even expansions, is lowering barriers to entry
Although GLP-1RAs can play a favorable role in improving heart failure based on pre-clinical studies, whereas some clinical evidence relevantly have reported that GLP-1RAs treatment could be associated with adverse heart failure events, eg
K., Brouwer, I
GLP-1 receptor agonists enhance insulin secretion when blood glucose levels are elevated, suppress glucagon release (which normally raises blood sugar), and slow gastric emptying
Subcutaneous injections use tiny needles, 29 to 31 gauge, which are thinner than a standard sewing needle